A single center prospective clinical study of Orelabrutinib in the treatment of relapsed/refractory autoimmune hemolytic anemia/Evans syndrome A single center prospective clinical study of Orelabrutinibin the treatment of relapsed/refractory a ...
A single center prospective clinical study of Orelabrutinib in the treatment of recurrent refractory autoimmune hemolytic anemia/Evans syndrome A single center prospective clinical study of Orelabrutinibin the treatment of recurrent refractory ...